UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                  SCHEDULE 13D

                   Under the Securities Exchange Act of 1934
                               (Amendment No.10 )*

                            Meris Laboratories Inc.
                                (Name of Issuer)

                                  Common Stock
                         (Title of Class of Securities)

                                   589848100
                                 (CUSIP Number)

JoAnn M. Strasser, Esq., Brown, Cummins, & Brown Co., L.P.A., 3500 Carew Tower,
             441 Vine Street, Cincinnati, Ohio 45202 (513) 381-2121
(Name, Address and Telephone Number of Person Authorized to Receive Notices
                               and Communications)

                                    11/13/96
            (Date of Event which Requires Filing of this Statement)

        If the filing person has  previously  filed a statement on Schedule G to
report the  acquisition  which is the subject of this  Schedule D, and is filing
this schedule because of Rule 13d-1(b) (3) or (4), check the following box. [ ]

        The remainder of this cover shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any  subsquenent  amendment  containing  information  which  would alter the
disclosures provided in a prior cover page.

        The  information  required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise  subject to the  liabilities of that section of
the Act but shall be subject to all other  provisions of the Act  (however,  see
the Notes).

1.NAME OF REPORTING PERSON
  S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
        Morton H. Sachs

2.CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*         (a)
                                                            (b) x
3.SEC USE ONLY

4.SOURCE OF FUNDS
        PF;OO

5.CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
  2(d) OR 2(e)  [  ]

6.CITIZENSHIP OR PLACE OF ORGANIZATION
        U.S.

NUMBER OF               7.  SOLE VOTING POWER               1,761,500
SHARES
BENEFICIALLY            8.  SHARED VOTING POWER                     0
OWNED BY




EACH                    9.  SOLE DISPOSITIVE POWER          1,761,500
REPORTING PERSON
WITH                   10. SHARED DISPOSITIVE POWER                 0


11.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
        1,761,500

12.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
          [  ]

13.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
        22.0%

14.  TYPE OF REPORTING PERSON*
        IN

                                       13D
                             Additional Information
Item #
1.(a) Name of Issuer:
        Meris Laboratories Inc.

  (b) Address of Issuer's Principal Executive Offices:
        110 Summit Avenue
        P.O. Box 460
        Montvale, NJ 07645

2.(a) Name of Person Filing:
        Morton H. Sachs
  (b) Address of Principal Business Office for Each of the Above:
        1346 South Third Street
        Louisville, KY  40208
  (c) Principal Occupation
        Investment Adviser
  (d) No
  (e) No
  (f) Citizenship:
        United States

3.Source and Amount of Funds or Other Consideration:
        Reporting Person  disclaims  beneficial  ownership of 1,364,500  shares,
which represents the shares beneficially owned by the advisory clients of Morton
H. Sachs & Company dba The Sachs Company (the "Disclaimed Shares").

        With respect to the Disclaimed Shares, the source of the aggregate 
purchase price of $9066 was the advisory clients for whose accounts the shares 
were purchased.  Shares owned directly by Reporting Person were purchased with 
personal funds and amounted to $103,125.

4.Purpose of the Transaction:
        The Disclaimed Shares were acquired for advisory clients' investment.
Reporting Person acquired the remaining shares for investment

5.Interest in Securities of the Issurer:
  (a) Reporting  person may be deemed to beneficially  own 1,761,500 shares
of common stock, representing 22.0% of the outstanding stock of the Issuer.

  (b) Reporting Person has sole power to vote or to direct the vote, and
sole power to dispose or to direct the  disposition of such  Reporting  person's
shares of the Issurer's stock.




  (c) See list below of transactions affecting beneficial ownership for Morton 
H. Sachs:

                                  


                             Price                  Trade
        Trade                 Per       Total       Affected
        Date        Shares   Share      Cost        Through
        ----        ------   -----      ----        --------
Purchases:
        11/12/96     2,500   1.150      2,874.98     Legg Mason
        11/12/96     5,000   1.238      6,190.62     Legg Mason
        11/13/96   100,000   1.031    103,125.00     Legg Mason




  (d) With respect to the Disclaimed Shares, each advisory client has the
right to receive dividends from, and proceeds from the sale of, its respective
shares.

  (e) N/A

6.  Contracts, Arrangements, Understandings or Relationships with Respect to 
Securities of the Issurer:
       Reporting Person has entered into no contracts, arrangements,
understandings or relationships with respect to securities of the Issuer.

7.  Materials to be Filed as Exhibits
        None

Reporting Person disclaims beneficial ownership of 1,364,500 shares, which
represents the shares beneficially owned by the advisory clients of Morton H.
Sachs & Company dba The Sachs Company.

        After reasonable inquiry and to the best of the undersigned's  knowledge
and belief, the undersigned certifies that the information set forth in this
Statement is true, complete and correct.


Dated as of:   November 13, 1996        Signature By:   /s/ Morton H. Sachs
Dated on:      February 26, 1997                        Morton H. Sachs